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Abstract 
The CD154 (CD40 ligand) molecule is a member of the tumor necrosis 
factor (TNF) family and plays an important role in the interaction between 
antigen-specific lymphocytes and antigen-presenting cells. In this study, reverse 
transcription–PCR cloning was used to derive the sequence encoding ovine 
CD154. Sequence analysis of the cloned CD154 gene showed a similarity of 97, 
89 and 88% with the bovine, porcine and human sequences, respectively, at the 
nucleic acid level. The deduced amino acid sequence for the ovine CD154 
shared 97, 91, and 87% similarity with the CD154 protein of bovine, porcine and 
human. The cysteine residues characteristic of the TNF family and N-linked 
glycosylation sites are conserved although one of the cysteine residues (Cys9) 
appeared only in ovine CD154. The isolated CD154 sequence was expressed as 
a mature protein in Chinese hamster ovary (CHO) cells. The analysis of 
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expression of ovine CD154 in mammalian cells by Western Blot confirmed the 
cross reactivity with anti-CD154 antibody.  
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1. Introduction 
The CD154 (CD40 ligand) molecule is produced as a type II 
transmembrane protein with a molecular mass of 33 kDa (Zhai et al., 2004). It is 
a member of the tumor necrosis factor (TNF) family of cell surface signaling 
molecules, and is expressed on activated CD4+ T cells and other cell types 
(Ferrant et al., 2002; Armitage, 1994). CD154 stimulates B cells to differentiate 
into antibody secreting and memory cells, and also boosts cell-mediated 
immunity by activation of macrophages and dendritic cells and the generation of 
natural killer cells and cytotoxic T lymphocytes (Ferrant et al., 2002; Vogel and 
Noelle, 1998). CD154 has a role in regulating the function of both the humoral 
and cell-mediated immune response. 
Progress towards successful DNA vaccines in large farm animals has 
been hampered by several factors including a relatively low response (Wang et 
al., 1998; Wang et al., 2001; Arulkanthan et al., 1999). Large numbers of 
plasmids containing cytokine sequences have been evaluated as DNA vaccine 
adjuvants (Scheerlinck, 2001). Plasmids have the advantage of being stable, 
simple to produce, and they can be genetically engineered to express any 
immunologic effectors or regulatory gene of interest (Barouch et al., 2004). 
Plasmid encoded cytokine adjuvants offer the possibility of exerting specific and 
potent immunostimulatory effects. Recently, studies in sheep have shown that 
co-administration of plasmid-encoded bovine CD154, increased antibody 
responses to bovine herpesvirus 1 glycoprotein D (Manoj et al., 2003).  
While previous studies in large animal species concluded that it is possible 
to enhance immune responses to DNA vaccination using various strategies, the 
role of cytokine molecules in enhancing immunity in domestic animals remains to 
be studied (Donnelly et al., 2003). It is well documented that cytokines may be 
involved not only in immunostimulatory role but also in development of 
undesirable pathological conditions (Buzoni-Gatel 2002). 
Bovine CD154 was cloned by (Mertens et al.,1995) and high homology with 
sheep CD154 is to be expected. However, to study immunoregulation in sheep, 
the identical molecule needs to be used. 
In this study we described the cloning, sequencing, sequence analysis and 
expression of ovine CD154 in Chinese hamster ovary (CHO) cells and 
characterization of the recombinant protein by Western Blot. Cloning and 
expression of this protein from ovine provides the basis for further investigation of 
role of CD154 in studying methods for enhancing immune responses to the 
proteins expressed by DNA vaccines. Recombinant cytokines are valuable tools 
for functional studies and analysis of the roles of different cytokines during 
immune responses.  
2. Materials and methods 
2.1 Molecular biology 
All reagents for polymerase chain reaction (PCR), reverse transcription 
PCR (RT-PCR), DNA, RNA and plasmid isolation and gel extraction kits were 
purchased from Qiagen (Hilden, Germany).  
2.2 Cells and tissues 
Whole blood (WB) from healthy sheep was anticoagulated with EDTA and 
diluted 1 in 10 with F-12 medium supplemented with 10% heat-inactivated fetal 
bovine serum (FBS), antibiotics (100 U/ml penicillin/100 μg/ml streptomycin, 2.5 
μg/ml amphotericin B (Fungizone). Lymphocyte stimulation was done in triplicate 
wells in 96-well microculture plates with 15 ng/ml of concanavalin A (Con A; 
Sigma–Aldrich (St. Louis, MO, USA). Cells were incubated for 48 h at 37°C in a 
humidified 5% CO2 air–water jacketed incubator.  
2.3 Cloning of ovine CD154 
RNA was obtained from normal adult sheep blood following of in vitro 
ConA stimulation using a Qiagen RNeasy kit. RNA was resuspended in 30 μl of 
RNase-free water and quantified by spectrophotometry (Optical density; OD260). 
RNA (3 mg) was used to synthesise single stranded complementary 
deoxyribonucleic acid (cDNA) with Qiagen Omniscript reverse transcriptase 
(5U/reaction), using anchored oligo-dT-primers . The cDNA-samples were stored 
at -30 °C. 
CD154 gene (791 base pairs; bp) was amplified by PCR of ovine WB 
cDNA using two oligonucleotide primers adcdfor (5′- CAG CAT GAT MGA AAC 
ATA CA -3′) and adcdrev (5′- TTC AGA GTT TGA GTA AGC CAA A -3′), which 
were designed on regions of high homology among the sequences of human and 
cattle CD154 (GenBank, accession numbers X67878 and Z48469 respectively). 
PCR was carried out in a total volume of 25μl reaction buffer containing 10 mM 
Tris-HCl (pH 9.0), 50 mM KCl, 1.25 mM MgCl2, 0.2 mM dNTPs, 5 U of Tag 
polymerase (Qiagen), 10 pmol each of the primers and 2 μl of cDNA. Cycling 
conditions for PCR were 10 cycles of 30 s at 95 °C, 30 s at 36 °C, 30 s at 72 °C 
and 30 cycles of 30 s at 95 °C, 30 s at 40 °C, 30 s at 72 °C, followed by the final 
extension for 7 min at 72 °C. The PCR product was cloned into pDrive cloning 
vector (Qiagen PCR Cloning Kit) and sequenced bidirectionally to confirm CD154 
specificity (plasmid pDriveCD154). Based on this sequence, two specific primers: 
(5′- GCG GAA TTC TCT AGA ATG GAC AAG ATA GAA GA -3′) and (5′- GCT 
CTA GAG GTA CCT CAG AGT TTG AGT AAG CCA A -3′) were designed for the 
amplification of the mature CD154 which started from 51 amino acid (aa) without 
transmembrane sequence. The ovine CD154 PCR product (668 bp) and 
pVAX1(Invitrogen) DNA were digested with XbaI (New England BioLabs, Beverly 
MA). Product was gel-purified and DNA ligations performed using T4 ligase and 
transformed to the DH5α cells (Invitrogen) according to the manufacturer’s 
description. Selected clones (referred to a pVAXCD154) were screened for 
recombinant protein CD154 by restriction enzyme analysis. 
2.4 Transfection and production of recombinant proteins 
To obtain recombinant protein CD154 for in vitro assays, CHO cells 
(American Type Culture Collection, ATCC) were cultured at a concentration of 
6X105 cells/ml in 60 mm diameter Petri dishes (Nurc, Falcon?) in F-12 medium 
(cat no.) with 10% FBS, 100 U/ml penicillin/100 μg/ml streptomycin, 2.5 μg/ml 
amphoterica B (Fungizone). Subsequently the cells were transfected with 
pVAXCD154 using Escort reagent (Sigma-Aldrich) according to the 
manufacturer’s instructions and cultured for 48 hr at 37 °C in 5% CO2 humidified 
environment. The pVAX1 (Invitrogene) and pVAX1lac (Invitrogene) were used as 
a control of transfection and expression of the recombinant protein.  
2.5 Western blot analysis 
CHO cell supernatant containing CD154 recombinant protein was 
separated on 12% polyacrylamide gel under reducing condition and the proteins 
were transferred to nitrocellulose membrane (Bio-Rad Laboratories, Hercules, 
CA). The nitrocellulose transfer was made by using the Mini Trans-Blot Cell (Bio-
Rad Laboratories) for 1 h at 200 mA. After treatment with 5% nonfat dry milk 
(Blotting Grade Blocker, Bio-Rad Laboratories) in Tris buffer containing 0.05% 
Tween 20, an for 1 h at room temperature (RT) under agitation with a human 
CD154-specific monoclonal antibody (1:1000) (Calbiochem, San Diego, CA, 
USA), 1:2000 final dilution, was performed. This was followed by a further 
incubation (1 h at room temperature) with anti-mouse IgG-horseradish 
peroxidase (Sigma-Aldrich 1:10,000 final dilution). Colorimetric detection was 
achieved by using 4-chloro-1-naphthol as substrate for horseradish peroxidase 
(Opti-4CN, Bio-Rad Laboratories) following the manufacturer’s instructions. 
2.6 Sequence analysis 
Plasmid pDriveCD154 was sequenced at Waikato DNA Sequencing 
Facility (Hamilton, New Zealand). Sequence data analyses were performed using 
the BLAST search of the National Center for Biotechnology Information. The 
protein prediction was performed using software at the ExPASy Molecular 
Biology Server (http://expasy.pku.edu.cn). Levels of similarity and identity 
nucleotide and amino acid sequence were determined wit the CLUSTALX and 
the GeneDoc programs. The sequence data have been submitted to GenBank 
and assigned accession number DQ054533 for CD154 cDNA. Phylogenetic 
analysis was performed using the CLUSTALX program and TREEVIEW version 
1.6.6 was used for visualization of the tree. 
 
3. Results 
3.1 cDNA cloning and sequence analysis of sheep CD154 
Total cDNA was made from total cellular RNA isolated from activated WB 
from healthy sheep and used as a template for the synthesis of CD154 cDNA. A 
PCR product was amplified using degenerate primers adcdfor and adcdrev, 
based on the DNA alignment of CD154 sequences from human and cattle. The 
identity of the product was confirmed by DNA sequencing (Fig.1) and aligned to 
known CD154 sequences from GenBank.  
The full-length CD154 mRNA is 787 nucleotides (GenBank accession no. 
DQ054533). The nucleotide sequence of ovine CD154 (oCD154) shared 97% 
similarity to cattle, 89% to pig CD154 and 88% to human and cat sequences 
(Tab1.).  
3.2. Amino acid sequence analysis of oCD154 
Comparison of the deduced amino acid sequence of the CD154 from 
sheep with the sequence of cattle, pig, cat, dog, mouse and human (Tab.1) 
indicated that the deduced protein had a higher degree of similarity to cattle (97% 
of amino acid identity) than to pig (89%), cat and human sequence (88% of 
homology) (Fig.2). The similarities results were further confirmed by the 
phylogenetic analysis (Fig. 3). The oCD154 showed close relationship between 
sheep and cattle and pig CD154. 
Search for conserved domain motifs revealed the presence 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) of a Tumor Necrosis Factor 
(TNF) domain in the C-terminal region of CD154 (Fig.1). In the TNF domain, the 
ovine sequence was 97%, 92%, and 90% identical to the TNF region of cattle, 
pig and human CD154, respectively. The lowest homology of the TNF sequence 
with ovine sequence was found for dog (84%) and mouse (75%). 
The analysis of the oCD154 sequence by the NetNGlyc 2.0 software 
(http://www.expasy.org) revealed that the sheep homologue of CD154 contained 
one potential N -glycosylation site located at the TFN domain. This N residue was 
conserved in the aligned sequenced from cattle, pig, cat, dog, mouse and human 
CD154. The 261 amino-acid sequence of oCD154 contain six cysteine (Cys) 
residues whereof one of them is characteristic only for sheep Cys9 and one 
Cys194 is present in all compared sequence excepting mouse. 
The molecular weight of the predicted CD154 is 29.271,77 Da, with the 
calculated PI being 8.83. 
3.3. Expression of CD154 gene in mammalian cells 
For the expression of oCD154 protein in a eukaryotic expression system 
the recombinant plasmid was constructed. The mature fragment of oCD154 
without transmembrane sequence was amplified by PCR. The 668 bp PCR 
product of oCD154 was cloned into the mammalian expression vector pVAX1 
behind the CMV promoter. The resultant construct named pVAXCD154 was then 
used to transfect CHO cells. As a control of the expression we used commercially 
available plasmid pVAXlac. For protein characterization of the expressed 
oCD154, Western Blot analysis was performed with the human CD154 specific 
monoclonal antibody. The Western Blot analysis with indicated a molecular 
weight of 23 kDa for the ovine CD154 without its signal anchor sequence was 
performed. Fig. 4. 
5. Discussion 
The CD154 is known to play an important role in cellular and humoral 
immune response (van Kooten and Banchereau, 2000). In this study we report 
the cloning, sequencing, nucleotide and amino acid sequences analysis and 
expression of ovine CD154 in mammalian cells. We designed our PCR primers 
based on regions of high homology among the sequences of CD154 genes from 
cattle and human and we analyzed obtained nucleotide and deduced amino acid 
sequence of oCD154 gene.  
DNA vaccines have a number of additional potential advantages 
compared to the conventional vaccines in terms of economy and simplicity of 
vaccine production. Numerous studies have confirmed that plasmid based DNA 
vaccine can induce protective immune responses in mice, but similar vaccine 
efficiency has not been observed for large animals species (Drew et al., 2001, 
van Drunen Littel-van den Hurk et al., 2000). Wang et al., 2001, Arulkanthan et 
al., 1992) Improving the immunogenicity of DNA vaccines especially in livestock 
animals (e.g. swine, cattle and sheep remains a major challenge (Krishnan and 
Rajendra, 2000). Some studies have showed a variety of ways to boost immune 
responses by changing the delivery parameters (van Rooij et al., 1998) and 
improving the transfection efficiency (Braun et al., 1999) or by adding immune 
modulatory molecules such as: cytokine (e.g. CD154) and costimulatory 
molecules (van Drunen Littel-van den Hurk et al., 2004). 
The nucleotide sequence of the oCD154 coding region has higher 
homology to cattle (97%) than to porcine (89%), human (88%), cat (88%), dog 
(86%) and mouse (80%).  
Amino acid sequence of oCD154 encodes 261 amino acid polypeptides 
which contain 24 amino acid long transmembrane domain, and 22 amino acid 
long, N-terminal intracellular domain and 140 amino acid TNF domain. Deduced 
amino acid sequence of oCD154 showed a high degree of homology to 
respective CD154 from cattle (97%), pig (91%) though relatively lower homology 
to human (87%), cat (86%), dog (83%) and mouse (77%). Therefore, these 
results revealed a close phylogenetic relationship between ovine and cattle and 
pig. The ovine CD154 gene high homology was expected, since other TNF 
superfamily members like: TNF-alpha, lymphotoxin-alpha, Apo2L, Fas ligand, 
and osteoprotegerin ligand genes (Bodmer et al., 2002), shares high identity in 
TNF domain, which determines 54% of amino acid sequence of oCD154. In the 
TNF domain the ovine sequence was 97%, 92% and 90% identical to the TFN 
region of cattle, pig and human CD154 respectively. 
The level of homology suggested that the oCD154 would be active on 
another B cells of the heterologous species especially on cattle and pig which 
shown the higher homology in CD154 sequence than other species. Bovine and 
ovine CD40 are 95% homologous at the amino acid level (Manoj et al., 2003). 
Murine CD154 has been shown that to mediate B-cells proliferation as well as 
IgE production in human B cells (Armitage et al., 1992a, Armitage et al., 1992b) 
and human CD154 is active on both murine and human B cells (Spriggs et al., 
1992). Analysis of the similarity of amino acid sequence of the murine CD40 
(mCD40) and human CD40 (hCD40) which shared 62% identity suggested that 
the binding of both mCD154 and hCD154 to either form of CD40 would be 
possible (Torres and Clark, 1992, Spriggs et al., 1992). 
The observed crossreactivity in our experiment between a mouse 
monoclonal anti-human CD154 antibody and the ovine CD154 in the Western 
Blot analysis support the described homology of the protein sequence. The 
similar immunology crossreactivity was confirmed for the porcine, mouse and 
human CD154 (Wienhold et al., 2002, Gauchat et al., 1993, Maliszewski et al., 
1993, Fanslow et al., 1994) 
CD154 is expressed on T cells following activation (Castle et al., 1993) 
and has a critical role in the generation on of both cells mediated and humoral 
immune responses, as well as regulation of antigen presenting cell activity (van 
Kooten and Banchereau, 2000). Several studies on the interactions between 
CD40 and CD154 have contributed extensively to our understanding of how both 
humoral and cellular immune responses are regulated (Grewal and Flavell., 
1998). This raises the possibility that response to a DNA vaccine may be 
enhanced by using CD154 as an adjuvant. 
In addition, recent research has shown that murine CD154 can function as 
an adjuvant for DNA vaccines by co-administering plasmids that individually 
express a vaccine antigen and CD154. The expression of CD154 appeared to 
enhance both immune responses and disease protection (Mendoza et al., 1997, 
Gurunathan et al., 1998, Tripp et al., 2000). Some studies have shown that co 
administration of plasmid encoded bovine CD154 enhanced antibody responses 
to bovine herpesvirus I glycoprotein D in sheep (Manoj et al., 2003). Bovine 
CD154 was used to enhance sheep humoral immune response induced by DNA 
vaccine. Plasmid encoding CD154 was used as an effective genetic adjuvant 
together with plasmid encoding GM-CSF gene. That combination of plasmids 
gives strong humoral immune responses against a plasmid encoding antigen 
(Burger et al., 2001). 
In conclusion co-expression of CD154 can be used to enhance humoral 
immune responses induced by a DNA vaccine. However, when using this 
approach for vaccination, it may be important to carefully consider the biological 
activity of both the vaccine antigen and the CD154 molecule to ensure that the 
both proteins does not have competing receptors binding activities as pointed out 
by Manoj et al. 2003.  
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atgatcgaaacatacagtcaaccttgtccccgctctgtggccactggcacacctgtcagt 
 M  I  E  T  Y  S  Q  P  C  P  R  S  V  A  T  G  T  P  V  S  
atgaaaatttttatgtatttacttactgtttttcttatcacccagatgattgggtcagcg 
 M  K  I  F  M  Y  L  L  T  V  F  L  I  T  Q  M  I  G  S  A  
ctttttgctgtgtatcttcacagaagattggacaagatagaagatgaaaggaatcttcac 
 L  F  A  V  Y  L  H  R  R  L  D  K  I  E  D  E  R  N  L  H  
gaagactttgtgttcatgaaaacgatacagagatgcaataaaggagaggggtccttatcc 
 E  D  F  V  F  M  K  T  I  Q  R  C  N  K  G  E  G  S  L  S  
ttactcaactgtgaggaaattagaagccggtttgaagacttggtcaaggatataatgcaa 
 L  L  N  C  E  E  I  R  S  R  F  E  D  L  V  K  D  I  M  Q  
aacaaagaagtaaagaagaaagaaaaaaactttgaaatgcacaaaggtgatcaggagcct 
 N  K  E  V  K  K  K  E  K  N  F  E  M  H  K  G  D  Q  E  P  
caaatagcagcacatgtcatcagtgaggccagtagtaaaacaacctctgttctccagtgg 
 Q  I  A  A  H  V  I  S  E  A  S  S  K  T  T  S  V  L  Q  W  
gcccccaaaggatactacaccctaagcagcaacctggtaaccctcgaaaacgggaaacag 
 A  P  K  G  Y  Y  T  L  S  S  N  L  V  T  L  E  N  G  K  Q  
ctggccgtgaaaagacaaggattctattacatctacacccaagtcaccttctgttccaat 
 L  A  V  K  R  Q  G  F  Y  Y  I  Y  T  Q  V  T  F  C  S  N  
cgggaagctttgaatcaagctccatttatagccagcctctgcctgaagtccccaagtgga 
 R  E  A  L  N  Q  A  P  F  I  A  S  L  C  L  K  S  P  S  G  
tcggagagaatcttactgagagctgcaaacacccacagttcttccaaaccatgcgggcag 
 S  E  R  I  L  L  R  A  A  N  T  H  S  S  S  K  P  C  G  Q  
caatccattcacttgggaggagtctttgaattgcaacagggtgcttcggtgtttgtcaat 
 Q  S  I  H  L  G  G  V  F  E  L  Q  Q  G  A  S  V  F  V  N  
gtgactgatccaagtcaggtgagccacgggactggcttcacatcatttggcttactcaaa 
 V  T  D  P  S  Q  V  S  H  G  T  G  F  T  S  F  G  L  L  K  
ctctga 
 L  -   
Fig.1. The nucleotide (GenBank accession numbers: DQ054533) and deduced 
amino acid sequences for ovine CD154. Italicized amino acid residues indicate 
the transmembran sequence while the underlined fragment represents the 
predicted N -glycosylated sites. Bold amino acid is CD154 conserved domain 
Tumor Necrosis Factor (TNF).  
  
 
 
 
 
 
Fig.2. Alignment of deduced amino acid sequence of sheep (GenBank accession 
no. DQ05453), cattle (GenBank accession no. Z48469), pig (GenBank accession 
no. AB04044), human (GenBank accession no. X6787), cat (GenBank accession 
no. AF07910), dog (GenBank accession no. AF08671) and mouse CD154 
(GenBank accession no. AY41606). Boxed sequence is CD154 conserved 
domain TNF.  
  
 
 
 
 
 
 
 
 
 
Fig.3. Phylogenetic relationship between sheep and other mammalian CD154. 
The sequence alignment was performed and the tree wee drawn as described in 
Materials and Methods.  
 
  
 
 
 
 
 
 
 
 
 
 
Fig. 4.  Analysis of ovine CD154 by Western blot.  
 
 
Species Sheep 
DQ054533 
Cattle
Z48469
Pig 
AB040443
Cat 
AF079105
Dog 
AF086711 
Human 
X67878
Mouse 
AY416063
Nu
cl
eo
ti
de
 S
eq
ue
nc
e 
Id
en
ti
ty
 (
%)
 ---- 97 89 88 86 88 80 Sheep 
---- 89 88 85 88 80 Cattle 97 
---- 87 85 86 79 Pig 91 91 
---- 90 87 79 Cat 86 86 84 
---- 85 78 Dog 83 83 81 92 
---- 83 Human 87 88 85 84 82 
---- 78 75 73 73 Mouse 77 77 
 
Amino Acid Sequence Identity (%) 
 
 
Tab.1. The nucleic and amino acid sequences % similarities of CD154. Bold 
section: percentage of nucleic acid.  
 
 
 
 
